| PERIOD ENDING | 30-Sep-09 | 30-Jun-09 | 31-Mar-09 | 31-Dec-08 | | Total Revenue | 20,186 | 20,661 | 15,681 | 11,514 | | Cost of Revenue | (11,086) | 11,086 |
-
| (15,982) | | | Gross Profit |
-
| 9,575 | 15,681 | 27,496 | | | Operating Expenses | | Research Development |
-
|
-
|
-
|
-
| | Selling General and Administrative | 21,896 | 1,565 | 8,460 | 24,447 | | Non Recurring |
-
| (1,237) | 1,237 | (11,243) | | Others |
-
| (1,106) | 1,106 | 17,755 | | | | Total Operating Expenses |
-
|
-
|
-
|
-
| | | | Operating Income or Loss |
-
| 10,353 | 4,878 | (3,463) | | | Income from Continuing Operations | | Total Other Income/Expenses Net | (1,455) | 1,455 |
-
|
-
| | Earnings Before Interest And Taxes | 8,342 | 13,006 | 4,732 | (11,253) | | Interest Expense | 3,500 | 3,589 | 3,477 | 4,236 | | Income Before Tax | 4,842 | 9,417 | 1,255 | (15,489) | | Income Tax Expense | 1,254 | 440 | 263 | 19,959 | | Minority Interest | (3,167) |
-
|
-
| 496 | | | | Net Income From Continuing Ops | 1,894 | 8,977 | 992 | (34,952) | | | Non-recurring Events | | Discontinued Operations |
-
|
-
|
-
| 145 | | Extraordinary Items |
-
|
-
|
-
|
-
| | Effect Of Accounting Changes |
-
|
-
|
-
|
-
| | Other Items |
-
|
-
|
-
|
-
| | | | Net Income | 421 | 8,977 | 992 | (34,807) | | Preferred Stock And Other Adjustments | 1,579 | (1,231) | (348) |
-
| | | Net Income Applicable To Common Shares | $2,000 | $7,746 | $644 | ($34,807) |
|
0.22% Nasdaq 
Income Statement
